| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 18, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the U. S. Food & Drug Administration (FDA) has issued an approvable letter for Dexcel Pharma Technologies, Ltd.'s New Drug...
-
Nov 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on December 19, 2006 to shareholders of record...
-
Nov 9, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) has released the following information regarding its voluntary recall announced early this morning. The voluntary recall was tied to certain lots of...
-
Nov 9, 2006(Nationwide Recall of Acetaminophen 500 Mg Caplets)
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has initiated a voluntary, nationwide product recall to the retail level of certain lots of its store brand Acetaminophen 500...
-
Oct 31, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its fiscal year 2007 first quarter that ended September 30, 2006. Perrigo Company (in thousands, except per share...
-
Oct 24, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2007 on Tuesday, Oct. 31, 2006 at approximately 8:30 a.m. (ET). The...
-
Oct 9, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today welcomed Joe Papa as its President and Chief Executive Officer. Mr. Papa succeeds Dave Gibbons who is now the Company's Executive Chairman of...
-
Oct 3, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) will conduct a brief conference call at 10:00 a.m. (ET) on October 10, 2006 introducing Joe Papa as President and Chief Executive Officer. There will be...
-
Oct 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has been granted tentative approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application...
-
Sep 25, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the- counter (OTC)...
-
Sep 11, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors has elected Joseph C. Papa as its President and Chief Executive Officer effective October 9. Mr. Papa...
-
Sep 1, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Perrigo Israel Pharmaceuticals subsidiary has been granted tentative approval from the U. S. Food and Drug Administration...
-
Aug 11, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on September 19, 2006 to shareholders of...
-
Aug 9, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the full year and fourth quarter ended July 1, 2006. Perrigo Company (in thousands, except per share amounts) Fourth...
-
Aug 7, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its partner, InvaGen Pharmaceuticals, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) on...
-
Aug 1, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fiscal year 2006 on Wednesday, Aug. 9, 2006 at approximately 8:30 a.m. (ET). The Company...
-
Jul 6, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Judy L. Brown has assumed the role of Executive Vice President, Chief Financial Officer and Chief Accounting Officer effective...
-
Jun 29, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its partner, Kali Laboratories, Inc., a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), has received...
-
Jun 27, 2006
Since the acquisition of Agis, Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) has pursued opportunities to integrate both businesses and to make them as efficient as possible, while at the same time...
-
Jun 14, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U. S. Food and Drug Administration (FDA) to market over-the-counter (OTC) coated nicotine...
-
Jun 7, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announces its association with Dexcel Pharma Technologies, Ltd.'s new drug application for a generic version of Prilosec OTC®. Under the terms of an...
-
May 12, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on June 20, 2006 to shareholders of record on...
-
May 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) invites the public to access a webcast of Chairman, President and CEO, David Gibbons' presentation at the Bank of America 2006 Health Care Conference...
-
May 4, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today acknowledges its association with the patent challenge of NASACORT® AQ initiated by Barr Laboratories, Inc. a subsidiary of Barr Pharmaceuticals,...
-
Apr 27, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter of fiscal year 2006 ended March 25, 2006. The acquisition of Agis Industries was completed on March 17,...